Stockscreener 앱 받기
184.27
0.08%
0.1447
시간 외 거래:
184.35
0.0776
+0.04%
전일 마감가:
$184.13
열려 있는:
$183.04
하루 거래량:
5,681
Relative Volume:
0.84
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.47%
1개월 성능:
-6.54%
6개월 성능:
+9.96%
1년 성능:
+13.43%
1일 변동 폭
$183.04
$184.87
1주일 범위
$183.04
$189.12
52주 변동 폭
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
Compare BBH vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
184.27 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.44 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
659.80 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.93 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.35 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf 주식(BBH)의 최신 뉴스
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - Yahoo Finance
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - The Globe and Mail
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps - Bitget
Why Is Vertex Pharmaceuticals Stock Soaring Tuesday?Vertex Pharmaceuticals (NASDAQ:VRTX) - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance Singapore
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
How to Invest in VanEck Biotech ETF (BBH) - The Motley Fool
True Market-Cap Exposure to Communication Services - VanEck
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg.com
Moderna’s rally ripples through biotech and health care ETFs - MSN
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize? - Seeking Alpha
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
December Market Recap: Innovation Matures, Constraints Tighten, Money Evolves - VanEck
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Healthcare Stocks In Focus: Assessing The Outlook For 2026 - Seeking Alpha
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
Plan for 2026: Predictions from Our Portfolio Managers - VanEck
The Next Phase of Retail: How Consumer Behavior and Technology Are Shaping the Industry - VanEck
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
Vaneck Biotech Etf (BBH) 재무 분석
Vaneck Biotech Etf (BBH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
0.24%
자본화:
|
볼륨(24시간):